SAREPTA THERAPEUTICS, INC. for SAREPTA THERAPEUTICS, INC.
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Pharmaceutical innovation, precision medicine, rare diseases, platform technologies, Innovation For Healthier Americans H.R. 6 - 21st Century Cures S. 2030 - Advancing Targeted Therapies for Rare Diseases Act of 2015 S. 2700 - FDA and NIH Workforce Authorities Modernization Act S. 2713 - Advancing Precision Medicine Act of 2016 S. 2742 - Promoting Biomedical Research and Public Health for Patients Act S. 1878 - Advancing Hope Act S. 1597 - Patient Focused Impact Assessment Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| JASON BARRON | — |
| DIANE BERRY | Staff Dir., Subcomm., House Committee on Homeland Security |
Medicare/Medicaid MMM
Medicaid Program and Pharmaceuticals
| Lobbyist | Covered position, as disclosed |
|---|---|
| DIANE BERRY | Staff Dir., Subcomm., House Committee on Homeland Security |
Budget/Appropriations BUD
H. Con. Res. 27 - House budget resolution S. Con. Res. 11 - Senate budget resolution H.R. 1314 - Bipartisan Budget Act of 2015 H.R. 2029 - Consolidated Appropriations Act, 2016
| Lobbyist | Covered position, as disclosed |
|---|---|
| JASON BARRON | — |
| DIANE BERRY | Staff Dir., Subcomm., House Committee on Homeland Security |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.